Qure.ai has successfully secured $65 million in its series D funding round. The investment will be utilized to enhance its offerings in the AI healthcare sector.

Qure.ai is a health tech company that uses deep learning and Artificial Intelligence (AI) to make healthcare more accessible and equitable for patients worldwide. Our solutions power the efficient identification and management of Tuberculosis (TB), Lung Cancer and Stroke to support clinicians and propel developments in the pharmaceutical and medical device industries. We empower healthcare by helping to identify conditions fast, prioritize treatment planning and ultimately improve the quality of patient life.


Qure.ai raised $65M in a series D funding round to advance its AI healthcare solutions.

Description

Company Information

Related People

Funding Insights